Cited by 66Sirtuins and Resveratrol in MedicineMuscle Physiology and DisordersAdipose Tissue and Metabolism

SIRT1 signaling as potential modulator of skeletal muscle diseases

Tonkin, Joanne, Villarroya, Francesc, Puri, Pier Lorenzo, Vinciguerra, Manlio·2012·Current Opinion in Pharmacology

Abstract

Skeletal muscle diseases heavily impair the strength and the movement of patients. Muscles loose their adaptive capacity, undergoing atrophy or wasting, due to a number of pathological insults. Metabolic changes, such as those occurring during aging, contribute to the progressive reduction of myofiber size and decline of skeletal muscle performance that is typically observed in the elderly. The nicotinamide adenine dinucleotide (NAD)-dependent deacetylase SIRT1 has been involved in the protection against metabolic disorders, against cancers and in the enhancement of life span. Here we discuss the current evidence placing SIRT1 at the crossroad between energy homeostasis, fiber strength, and regeneration from damage in the skeletal muscle. Furthermore, we underline how cell type specific targeting of SIRT1 could be beneficial in the treatment of skeletal muscle diseases.

Integrity signals

Registry

Crossref · 10.1016/j.coph.2012.02.010

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tonkin, J., Villarroya, F., Puri, P. L., & Vinciguerra, M.
Affiliations
  • European Molecular Biology Laboratory (IT)
  • Centro de Investigación Biomédica en Red (ES)
  • Foundation for Liver Research (GB)
Corresponding author
Vinciguerra, Manlio
Venue
Current Opinion in Pharmacology
Publisher
Elsevier BV
Published
2012-06
Volume
12
Issue
3
Pages
372-376
ISSN
1471-4892 (ISSN-L)
OpenAlex
W1991156731
Cited by
60
References
48
Citations by year
2025: 3 · 2024: 13 · 2023: 4 · 2022: 3 · 2021: 4 · 2020: 4 · 2019: 1 · 2018: 6 · 2017: 4 · 2016: 3 · 2015: 5 · 2014: 2 · 2013: 3 · 2012: 5
FWCI
0.40
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Nottingham Trent University's Institutional Repository (Nottingham Trent Repository) (submittedVersion)
Funders
Foundation for Liver Research (London, UK)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
SIRT1, skeletal muscle disorders, muscle atrophy, NAD+-dependent deacetylase, energy homeostasis, muscle regeneration, aging, sarcopenia, cell type-specific targeting
MeSH terms
Aging, Animals, Humans, Macrophages, Muscular Diseases, Regeneration, Signal Transduction, Disease Progression, Muscle, Skeletal, Satellite Cells, Skeletal Muscle, Cell Proliferation, Sirtuin 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review